Allosteric Modulators of HSP90 and HSP70: Dynamics Meets Function through Structure-Based Drug Design | Journal of Medicinal Chemistry
Allosteric Modulators of HSP90 and HSP70: Dynamics Meets Function through Structure-Based Drug Design | Journal of Medicinal Chemistry
Vasilis Daniil - Process Engineer - Papastratos S.A. | LinkedIn
Konstantin Tsanev - Process Engineer - Philip Morris International | LinkedIn
Anastasios Kontos on LinkedIn: Electrical Technician
Athanasios Katsimigos - Process Control Engineer RRP - Philip Morris International | LinkedIn
Serafeim Kouratiadis - Production Operator in Department of Secondary - Papastratos S.A. | LinkedIn
Patmos Projects | Photos, videos, logos, illustrations and branding on Behance
Zisis Lemonis - Civil Engineer - Self-employed | LinkedIn
Zisis Lemonis - Civil Engineer - Self-employed | LinkedIn
Argyro Dimitratou - Supervisor Quality Control - Philip Morris International | LinkedIn
Serafeim Kouratiadis - Production Operator in Department of Secondary - Papastratos S.A. | LinkedIn
XANTHI BELLOU - Process Lead - Philip Morris International | LinkedIn
Vasiliki Gialouri - Validation Engineer - Philip Morris International | LinkedIn
Dimitris Psichoulas - Greece | Professional Profile | LinkedIn
Alessandro Coppola - Process Engineer - Philip Morris International | LinkedIn
Theodoros Kaltsis - Process Technician - Papastratos | LinkedIn
Aristotelis Apostolou | LinkedIn
Anastasios Tsioukis - Process Technician - Papastratos S.A. | LinkedIn
Maria Niotaki - Greece | Professional Profile | LinkedIn
Argyro Dimitratou - Supervisor Quality Control - Philip Morris International | LinkedIn
Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design | Journal of Medicinal Chemistry
Membrane Allostery and Unique Hydrophobic Sites Promote Enzyme Substrate Specificity | Journal of the American Chemical Society
Argyro Dimitratou - Supervisor Quality Control - Philip Morris International | LinkedIn
Nikolaos Stratis-Lamprakis | LinkedIn
The Discovery of a Potent, Selective, and Peripherally Restricted Pan-Trk Inhibitor (PF-06273340) for the Treatment of Pain | Journal of Medicinal Chemistry
